Jung-Woo Choi Selected Research

Fatty Acid Transport Proteins (Fatty Acid Transport Protein)

4/2022	Significance of Altered Fatty Acid Transporter Expressions in Uterine Cervical Cancer and Its Precursor Lesions.
1/2021	Upregulation of Fatty Acid Transporters is Associated With Tumor Progression in Non-Muscle-Invasive Bladder Cancer.
1/2019	High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung-Woo Choi Research Topics

Disease

17	Neoplasms (Cancer) 04/2022 - 07/2006
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 01/2015
4	Renal Cell Carcinoma (Grawitz Tumor) 04/2020 - 10/2011
4	Lymphatic Metastasis 10/2018 - 08/2011
3	Carcinogenesis 01/2022 - 09/2014
3	Neoplasm Metastasis (Metastasis) 08/2021 - 10/2011
3	Breast Neoplasms (Breast Cancer) 10/2018 - 08/2011
3	Carcinoma (Carcinomatosis) 07/2014 - 11/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 02/2007
2	Foreign Bodies (Foreign Body) 02/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 09/2011
2	Aneuploidy (Aneuploid) 09/2014 - 11/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2013 - 02/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022
1	Squamous Intraepithelial Lesions 04/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Lymphoma (Lymphomas) 01/2022
1	Fecal Incontinence 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Hypoxia (Hypoxemia) 01/2015
1	Lymphadenopathy 01/2014
1	Neurofibroma 01/2014
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2013
1	Hematologic Neoplasms (Hematological Malignancy) 02/2013
1	Hearing Loss (Hearing Impairment) 01/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2012
1	Hodgkin Disease (Hodgkin's Disease) 04/2012
1	Cysts 02/2012
1	Colonic Neoplasms (Colon Cancer) 09/2011
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2007
1	Keratoacanthoma 02/2007
1	Melanoma (Melanoma, Malignant) 02/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2006
1	Epstein-Barr Virus Infections 07/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2011
3	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 04/2022 - 01/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 07/2014
3	TubulinIBA 04/2014 - 02/2007
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2011 - 07/2006
2	RNA (Ribonucleic Acid)IBA 08/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2006
2	SymportersIBA 01/2015 - 07/2014
2	Plasminogen Activator Inhibitor 1IBA 01/2013 - 10/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2013 - 10/2011
1	SiliconesIBA 02/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	LactatesIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	PolymersIBA 01/2022
1	Aurora Kinase AIBA 08/2021
1	Ligases (Synthetase)IBA 01/2021
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 10/2018
1	Circulating Tumor DNAIBA 10/2018
1	Immune Checkpoint InhibitorsIBA 12/2017
1	B7-H1 AntigenIBA 12/2017
1	Biological ProductsIBA 01/2015
1	Protons (Proton)IBA 07/2014
1	Coffee FDA Link 01/2014
1	Imatinib Mesylate (Gleevec)FDA Link 12/2013
1	milatuzumabIBA 02/2013
1	Plasminogen InactivatorsIBA 01/2013
1	PrionsIBA 11/2012
1	MucinsIBA 02/2012
1	Glycoproteins (Glycoprotein)IBA 08/2011
1	Matrix Metalloproteinases (MMPs)IBA 08/2011
1	TESIBA 02/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
1	Eyeglasses (Spectacles) 01/2013
1	Drug Therapy (Chemotherapy) 04/2012